BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28373073)

  • 1. Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.
    Pasquarelli N; Engelskirchen M; Hanselmann J; Endres S; Porazik C; Bayer H; Buck E; Karsak M; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2017 Sep; 124():157-169. PubMed ID: 28373073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
    Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease.
    Pasquarelli N; Porazik C; Bayer H; Buck E; Schildknecht S; Weydt P; Witting A; Ferger B
    Neurochem Int; 2017 Nov; 110():14-24. PubMed ID: 28826718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography study.
    Yamasaki T; Hatori A; Zhang Y; Mori W; Kurihara Y; Ogawa M; Wakizaka H; Rong J; Wang L; Liang S; Zhang MR
    Theranostics; 2021; 11(19):9492-9502. PubMed ID: 34646382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.
    Ignatowska-Jankowska BM; Ghosh S; Crowe MS; Kinsey SG; Niphakis MJ; Abdullah RA; Tao Q; O' Neal ST; Walentiny DM; Wiley JL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2014 Mar; 171(6):1392-407. PubMed ID: 23848221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model.
    Fernández-Suárez D; Celorrio M; Riezu-Boj JI; Ugarte A; Pacheco R; González H; Oyarzabal J; Hillard CJ; Franco R; Aymerich MS
    Neurobiol Aging; 2014 Nov; 35(11):2603-2616. PubMed ID: 24973119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.
    Hashem J; Hu M; Zhang J; Gao F; Chen C
    Mol Neurobiol; 2021 Aug; 58(8):4122-4133. PubMed ID: 33939165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.
    Chen X; Zhang J; Chen C
    Neuroscience; 2011 Mar; 178():159-68. PubMed ID: 21256197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice.
    Witting A; Weydt P; Hong S; Kliot M; Moller T; Stella N
    J Neurochem; 2004 Jun; 89(6):1555-7. PubMed ID: 15189359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
    Muldoon PP; Akinola LS; Schlosburg JE; Lichtman AH; Sim-Selley LJ; Mahadevan A; Cravatt BF; Damaj MI
    Neuropharmacology; 2020 Oct; 176():108170. PubMed ID: 32479813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.
    Du H; Chen X; Zhang J; Chen C
    Br J Pharmacol; 2011 Aug; 163(7):1533-49. PubMed ID: 21501147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
    Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
    Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.
    Zhang J; Chen C
    Mol Neurobiol; 2018 Jun; 55(6):4802-4810. PubMed ID: 28733897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor.
    Zou Z; Lu Y; Zha Y; Yang H
    J Mol Neurosci; 2016 Aug; 59(4):493-503. PubMed ID: 27129498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
    von Rüden EL; Bogdanovic RM; Wotjak CT; Potschka H
    Neurobiol Dis; 2015 May; 77():238-45. PubMed ID: 25796567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis.
    Nass SR; Steele FF; Ware TB; Libby AH; Hsu KL; Kinsey SG
    Cannabis Cannabinoid Res; 2021 Jun; 6(3):233-241. PubMed ID: 34042520
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
    Alhouayek M; Lambert DM; Delzenne NM; Cani PD; Muccioli GG
    FASEB J; 2011 Aug; 25(8):2711-21. PubMed ID: 21551239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
    Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
    Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.